Higashi C, Kawaji A, Tsuda N, Hayashi M, Saito R, Yagishita Y, et al
All substances decreased task-related brain reactivity of the DMN compared to the placebo, suggesting decreased task-related mind wandering
doi: 10.1016/j.disamonth.2015.08.001
The latest from Bodybuilding
GLP-1 Therapies: Balancing Clinical Benefits with Environmental Impact There is an irony: by tackling obesity and diabetes, GLP-1s could reduce the incidence of cardiovascular disease, kidney failure, and other conditions each of which carries a heavy environmental cost through surgeries, hospitalizations, and long-term drug use
A study (72) assessing the effects of resveratrol on metabolic parameters in ob/ob mice injected daily with resveratrol for 20 days or left untreated (as controls) showed that resveratrol: reduces testosterone reduces insulin levels reduced TNF- and IL-6 levels in adipose tissue In a rat model for PCOS (73), daily intraperitoneal injection of resveratrol for 4 weeks induced: a significant reduction in the number of antral follicle counts a significantly decreased plasma anti-Mullerian hormone and insulin-like growth factor 1 levels (playing a key role in PCOS metabolic disturbances) significantly lower superoxide dismutase activity significantly increased glutathione peroxidase which will reduce cell vulnerability to ROS
%25201.png)
